CAPRIOLI, FLAVIO ANDREA
CAPRIOLI, FLAVIO ANDREA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Management of Clostridioides difficile infection: an Italian Delphi consensus
2024 M. Bassetti, A. Cascio, F.G. De Rosa, M. Meschiari, R. Parrella, N. Petrosillo, A. Armuzzi, F. Caprioli, F. Dentali, M. Pani, A. Pilotto, U. Restelli, M. Sanguinetti
Role of the Microbiome in the Diagnosis and Management of Gastroesophageal Cancers
2024 F. Mascaretti, S. Haider, C. Amoroso, F. Caprioli, D. Ramai, M. Ghidini
The Epidemiology and Clinical Management of Short Bowel Syndrome and Chronic Intestinal Failure in Crohn’s Disease in Italy: An IG-IBD Survey.
2024 T. Pessarelli, M. Topa, A. Sorge, N. Nandi, D. Pugliese, F. Salvatore Macaluso, A. Orlando, S. Saibeni, A. Costantino, F. Stalla, V. Zadro, L. Scaramella, M. Vecchi, F. Caprioli, L. Elli
Timing of proper introduction, optimization and maintenance of anti-TNF therapy in IBD: Results from a Delphi consensus
2024 S. Ardizzone, A. Armuzzi, F. Caprioli, F. Castiglione, S. Danese, M. Daperno, M.C. Fantini, W. Fries, M.B. Principi, E. Savarino, P. Gionchetti
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus
2024 F.S. Macaluso, F. Caprioli, L. Benedan, C. Bezzio, R. Caporali, A. Cauli, M.S. Chimenti, F. Ciccia, S. D'Angelo, M.C. Fantini, S. Festa, F. Iannone, E. Lubrano, P. Mariani, C. Papi, G. Provenzano, D. Pugliese, A. Rispo, S. Saibeni, C. Salvarani, A. Variola, M. Zenga, A. Armuzzi, A. Orlando, R. Gerli
Costo per Number Needed to Treat (NNT) di upadacitinib nel trattamento dei pazienti bio-exposed con rettocolite ulcerosa attiva da moderata a grave
2024 F. Caprioli, M.C. Fantini, F. Marando, D. Scaduto, R. Ravasio
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study
2024 M. Allocca, G. Catalano, E.V. Savarino, M. Chaparro, A. Levartovsky, G. Michalopoulos, N. Viazis, F.S. Fousekis, A. Psistakis, D. Noviello, C.N.D. Nascimento, B. Caron, V. Kitsou, G. Bamias, M.J. García, E. Zacharopoulou, K. Foteinogiannopoulou, F. D'Amico, I. Koutroubakis, P. Ellul, M. Tzouvala, L. Peyrin-Biroulet, J. Torres, F. Caprioli, K. Karmiris, A. Theodoropoulou, K.H. Katsanos, D.K. Christodoulou, G.J. Mantzaris, U. Kopylov, J.P. Gisbert, S. Danese, F. Magro, F. Carla, G. Fiorino
Rates of adverse events in patients with ulcerative colitis undergoing colectomy during treatment with tofacitinib vs biologics: a multicenter observational study
2024 G. Dragoni, T. Innocenti, A. Amiot, F. Castiglione, L. Melotti, S. Festa, E.V. Savarino, M. Truyens, K. Argyriou, D. Noviello, T. Molnar, V. Bouillon, C. Bezzio, P. Eder, S. Fernandes, A. Kagramanova, A. Armuzzi, R. Oliveira, A. Viola, D.G. Ribaldone, I. Drygiannakis, C. Viganò, F. Calella, A.G. Gravina, D. Pugliese, M. Chaparro, P. Ellul, S. Vieujean, M. Milla, F. Caprioli
Risankizumab, but not ustekinumab or vedolizumab, downregulates IL-23-induced mucosal pathogenic Th17 cells in patients with Crohn’s disease
2024 D. Noviello, I. Dusetti, V. Pivorunas, A.E. Lovati, C. Ciafardini, C. Amoroso, F. Conforti, N. Piazza O Sed, M. Vecchi, F. Facciotti, M. Paroni, F. Caprioli
Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD)
2024 G. Bergamaschi, F. Castiglione, R. D'Incà, M. Astegiano, W. Fries, M. Milla, C. Ciacci, F. Rizzello, S. Saibeni, R. Ciccocioppo, A. Orlando, F. Bossa, M. Principi, P. Vernia, C. Ricci, M.L. Scribano, G. Bodini, D. Mazzucco, G. Bassotti, G. Riegler, A. Buda, M. Neri, F. Caprioli, F. Monica, A. Manca, E. Villa, G. Fiorino, N. Aronico, M.V. Lenti, C. Mengoli, A. Testa, M. Vecchi, C. Klersy, A. Di Sabatino
Pragmatic trial design to compare real-world effectiveness of different treatments for inflammatory bowel diseases: the PRACTICE-IBD European consensus
2024 M. Claudio Fantini, G. Fiorino, A. Colli, D. Laharie, A. Armuzzi, F.A. Caprioli, J. P Gisbert, J. Kirchgesner, F. Salvatore Macaluso, F. Magro, S. Ghosh
AIEC-dependent pathogenic Th17 cell transdifferentiation in Crohn's disease is suppressed by rfaP and ybaT deletion
2024 G. Leccese, M. Chiara, I. Dusetti, D. Noviello, E. Billard, A. Bibi, G. Conte, C. Consolandi, M. Vecchi, M.P. Conte, N. Barnich, F. Caprioli, F. Facciotti, M. Paroni
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease
2024 L. Peyrin-Biroulet, J.C. Chapman, J. Colombel, F. Caprioli, G. D'Haens, M. Ferrante, S. Schreiber, R. Atreya, S. Danese, J.O. Lindsay, P. Bossuyt, B. Siegmund, P.M. Irving, R. Panaccione, Q. Cao, E. Neimark, K. Wallace, T. Anschutz, K. Kligys, W.R. Duan, V. Pivorunas, X. Huang, S. Berg, L. Shu, M. Dubinsky
Italian validation of the IBD-disk tool for the assessment of disability in inflammatory bowel diseases: A cross-sectional multicenter study
2024 O.M. Nardone, D. Bruzzese, M. Allocca, G. Calabrese, F. Caprioli, S. Danese, M.C. Fantini, S. Onali, A. Orlando, A. Rispo, E. Savarino, A. Soriano, A. Testa, A. Variola, F. Castiglione
Transition care in patients with IBD: The pediatric and the adult gastroenterologist's perspective. Results from a national survey
2024 F. Castiglione, L. Scarallo, O.M. Nardone, M. Aloi, P. Alvisi, A. Armuzzi, S. Arrigo, G. Bodini, E. Calabrese, L. Ceccarelli, W. Fries, A. Marseglia, M. Martinelli, M. Milla, A. Orlando, A. Rispo, F. Rizzello, C. Romano, F. Caprioli, P. Lionetti
Immune-Mediated Inflammatory Diseases Awareness and Management among Physicians Treating Patients with Inflammatory Bowel Disease: An IG-IBD Survey
2024 M. Vernero, C. Bezzio, D.G. Ribaldone, F.A. Caprioli, M.C. Fantini, S. Festa, F.S. Macaluso, A. Orlando, D. Pugliese, S. Renna, A. Rispo, E.V. Savarino, A. Variola, S. Saibeni
Effect of Tofacitinib on One-Year Colectomy Risk in Anti-TNF Refractory Ulcerative Colitis: A Prospective Multicenter Italian Study
2024 A.M. Carvalhas Gabrielli, F. Ferretti, C.M. Monico, E. Tombetti, G. Maconi, S. Romeo, N. Piazza O Sed, F. Caprioli, A.M. Mazzola, S. Alicante, R. Bertè, E. Lolli, M.L. Scribano, E. Buscarini, C. Ricci, S. Carmagnola, S. Ardizzone, R. Cannatelli
Estrogen-related differences in antitumor immunity and gut microbiome contribute to sexual dimorphism of colorectal cancer
2024 G. Lattanzi, F. Perillo, A. Díaz-Basabe, B. Caridi, C. Amoroso, A. Baeri, E. Cirrincione, M. Ghidini, B. Galassi, E. Cassinotti, L. Baldari, L. Boni, M. Vecchi, F. Caprioli, F. Facciotti, F. Strati
Response to Wei-Zhen Tang et al
2024 G. Dragoni, T. Innocenti, F. Caprioli
Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease
2024 C. Bezzio, G. Franchellucci, E.V. Savarino, M. Mastronardi, F.A. Caprioli, G. Bodini, A. Variola, F. Scaldaferri, F. Furfaro, E. Calabrese, M.B. Principi, G. Biscaglia, M. Marzo, A. Michielan, C. Cavalli, A. Aratari, M. Campigotto, L. Ceccarelli, M. Cappello, S. Saibeni, P. Balestrieri, A. Soriano, V. Casini, L. Bertani, B. Barberio, F.S. Conforti, S. Danese, A. Armuzzi